PLUR Stock Summary and Trading Ideas (Pluri | NASDAQ:PLUR)

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Pluri trades on the NASDAQ stock market under the symbol PLUR.

As of October 23, 2026, PLUR stock price declined to $0.99 with 70,051 million shares trading.

PLUR has a beta of 0.23, meaning it tends to be less sensitive to market movements. PLUR has a correlation of 0.00 to the broad based SPY ETF.

PLUR has a market cap of $12.49 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, PLUR traded as high as $8.48 and as low as $.85.

PLUR has underperformed the market in the last year with a return of -74.5%, while the SPY ETF gained +14.3%. In the last 3 month period, PLUR fell short of the market, returning -44.8%, while SPY returned +3.2%. However, in the most recent 2 weeks PLUR has outperformed the stock market by returning +3.9%, while SPY returned -2.4%.

PLUR support price is $.93 and resistance is $1.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLUR shares will trade within this expected range on the day.